DE59708441D1 - Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten - Google Patents

Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten

Info

Publication number
DE59708441D1
DE59708441D1 DE59708441T DE59708441T DE59708441D1 DE 59708441 D1 DE59708441 D1 DE 59708441D1 DE 59708441 T DE59708441 T DE 59708441T DE 59708441 T DE59708441 T DE 59708441T DE 59708441 D1 DE59708441 D1 DE 59708441D1
Authority
DE
Germany
Prior art keywords
pct
disinegrating
nucleic acids
biological products
producing quality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59708441T
Other languages
English (en)
Inventor
Friedrich Dorner
Noel Barrett
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of DE59708441D1 publication Critical patent/DE59708441D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DE59708441T 1996-04-09 1997-04-08 Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten Expired - Fee Related DE59708441D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0062996A AT406778B (de) 1996-04-09 1996-04-09 Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
PCT/AT1997/000068 WO1997037686A1 (de) 1996-04-09 1997-04-08 Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten

Publications (1)

Publication Number Publication Date
DE59708441D1 true DE59708441D1 (de) 2002-11-14

Family

ID=3495662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59708441T Expired - Fee Related DE59708441D1 (de) 1996-04-09 1997-04-08 Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten

Country Status (6)

Country Link
US (1) US6165711A (de)
EP (1) EP0900087B1 (de)
AT (2) AT406778B (de)
DE (1) DE59708441D1 (de)
ES (1) ES2185003T3 (de)
WO (1) WO1997037686A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7900435A (nl) * 1979-01-19 1980-07-22 Doornes Transmissie Bv Samengestelde drijfriem met dwarselementen voorzien van onderlinge koppelingsmiddelen.
NL7900923A (nl) * 1979-02-06 1980-08-08 Doornes Transmissie Bv Samengestelde drijfriem voorzien van dwarselementen met koppelingsmiddelen, en dwarselement voor een drijfriem.
US4365965A (en) * 1980-09-08 1982-12-28 The Gates Rubber Company V-Block belt
US7186543B1 (en) * 1998-07-21 2007-03-06 Gambro Inc. Preparation of vaccines using a photosensitizer and light
US6843961B2 (en) 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US20020176796A1 (en) * 2000-06-20 2002-11-28 Purepulse Technologies, Inc. Inactivation of microbes in biological fluids
FR2810549A1 (fr) * 2000-06-27 2001-12-28 Laurent Galey Composition presentant une activite antiparasitaire et biologique
US20030060747A1 (en) * 2001-05-17 2003-03-27 Fries William M. Fluid flow path for a fluid treatment system using light for the decontamination of fluid products
US20030030011A1 (en) * 2001-05-17 2003-02-13 Purepulse Technologies, Inc. Light treatment control in a fluid treatment system using light for the treatment of fluid products
CA2921048C (en) * 2006-09-15 2018-06-05 Ottawa Hospital Research Institute Oncolytic rhabdovirus
US20140127077A1 (en) 2012-11-05 2014-05-08 Gail Rock Device and method for sterilization of instruments and surfaces
KR102178036B1 (ko) 2013-03-15 2020-11-13 디에스엠 아이피 어셋츠 비.브이. 핵산 분해를 위한 호열성 뉴클레아제의 용도
CN110115761B (zh) * 2019-05-09 2023-06-16 英诺激光科技股份有限公司 一种利用激光和载体技术制备疫苗的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3849685A (en) * 1984-02-16 1985-08-22 Molecular Biophysics Technology, Inc. Pusled light selective photcysis for sterilization of biological fluid
US4880512A (en) * 1984-02-16 1989-11-14 Kollmorgen Corporation Pulsed light selective photolysis process for treatment of biological media and products made thereby
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
AT389889B (de) * 1988-05-03 1990-02-12 Langenecker Bertwin Dr Verfahren und vorrichtung zum inaktivieren von in einem traegermedium enthaltenen viren
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US4950665A (en) * 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
WO1990013296A1 (en) * 1989-05-11 1990-11-15 Oklahoma Medical Research Foundation Antiviral therapy using thiazine and xanthene dyes
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
AU7954691A (en) * 1990-05-01 1991-11-27 American National Red Cross, The Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
JPH04131085A (ja) * 1990-09-19 1992-05-01 Hitachi Ltd レーザーを用いる細胞の変異株の取得方法
DE4403798A1 (de) * 1994-02-03 1995-08-10 Fouad Dipl Ing Khalil Verfahren zur Sterilisation des Blutes durch ultraviolette Strahlung, um alle Viren im Blut, insbesondere den HIV-Virus und Hepatitisvirus, abzutöten (Ziel ist es, diesen Virus im Blut ganz abzutöten)
US5494243A (en) * 1994-05-25 1996-02-27 Abc Rail Products Corporation Railroad switch stand with foot operated handle latch
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
US5663043A (en) * 1995-01-04 1997-09-02 Hemasure Inc. Method for inactivating non-enveloped viruses using a viricide-potentiating agent with a photoactivatible virucide

Also Published As

Publication number Publication date
ATA62996A (de) 2000-01-15
ES2185003T3 (es) 2003-04-16
ATE225669T1 (de) 2002-10-15
US6165711A (en) 2000-12-26
EP0900087B1 (de) 2002-10-09
EP0900087A1 (de) 1999-03-10
AT406778B (de) 2000-09-25
WO1997037686A1 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
DE59708441D1 (de) Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
ATE204162T1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
DE69128362D1 (de) Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
DK0473724T3 (da) Et humant cytokin, interleukin-9
DE59407012D1 (de) Desodorierende wirkstoffkombinationen auf der basis von wollwachssäuren und partialglyceriden
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
DE69031732T2 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
DE69600084D1 (de) Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln
DE122011100046I1 (de) In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.
DE59406050D1 (de) Verwendung von detergensgemischen zur herstellung von toilettensteinen
DE69425940D1 (de) Enzymatische synthese von ceramiden und hybrid-ceramiden
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
SE8801701D0 (sv) Production technology based on enzymic method
EP0787207A4 (de) Neue methode zum auffindenund bewerten biologisch aktiver moleküle
DE69014046D1 (de) Verzweigungsenzym und dessen Verwendung.
ATE222601T1 (de) Methode zur expression in und isolation von biologisch aktiven molekülen aus urin
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
ATE180837T1 (de) Verfahren zur herstellung von häm-proteinen
DE3851304T2 (de) Verfahren und Testzusammensetzung zur Bestimmung von Enzym-Aktivität.
DE69837212D1 (de) Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes
ATE283347T1 (de) Verwendung des pilzes gliocadium catenulatun zur biologischen kontrolle von pflanzenkrankheiten
DE3871322D1 (de) Verfahren zur kultur von pflanzengewebe.
ES2147781T3 (es) Metodo para obtencion de una produccion incrementada de una linea de celulas productora utilizando un protocolo de fusion.
ATA250593A (de) Modifizierte oligonukleotide, verfahren zu ihrer herstellung und verwendung als wirkstoffe zur herstellung von arzneimitteln
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee